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Background: The epithelial–mesenchymal transition (EMT) is crucial for the invasion and metastasis of breast
cancer. However, how Notch signaling regulates the EMT process and invasion in breast cancer remains largely
unknown.
Methods: The impact of Notch1 silencing by specific shRNAs on the EMT and invasion of human breast cancer
MCF-7 and MDA-MB-231 cells as well as xenografts was tested by western blot, real-time polymerase chain reaction
(RT-PCR), immunofluorescence, transwell, and immunohistochemistry assays. The effect of Slug silencing or upregulation
on the EMT and invasion of breast cancer cells was analyzed, and the effect of Notch1 signaling on Slug expression was
determined by the luciferase reporter assay.
Results: The Notch1 intracellular domain (N1ICD) and Jagged1 were expressed in breast cancer cells. Notch1 silencing
reversed the spontaneous EMT process and inhibited the migration and invasion of breast cancer cells and the growth
of xenograft breast cancers. The expression of N1ICD was upregulated significantly by Jagged1-mediated Notch signaling
activation. Moreover, Jagged1-mediated Notch signaling promoted the EMT process, migration, and invasion of breast
cancer cells, which were abrogated by Notch silencing. Furthermore, the N1ICD positively regulated the Slug expression
by inducing Slug promoter activation. Importantly, the knockdown of Slug weakened the invasion ability of breast cancer
cells and reversed the Jagged1-induced EMT process with significantly decreased expression of vimentin and increased
expression of E-cadherin. In addition, Slug overexpression restored the Notch1 knockdown-suppressed EMT process.
Conclusions: Our novel data indicate that Notch signaling positively regulates the EMT, invasion, and growth of breast
cancer cells by inducing Slug expression. The Notch1–Slug signaling axis may represent a potential therapeutic target for
breast cancer therapy.
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Breast cancer is one of the most frequently diagnosed
cancers and the leading cause of cancer death in females
worldwide. It accounts for 23% of total cancer cases and
14% of cancer deaths [1]. Although there have been sub-
stantial advances in the treatment of localized malignancies,* Correspondence: gushanzhi@mail.xjtu.edu.cn; zhaoxinhanprof@163.com
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remains the primary cause of breast cancer mortality [2].
Mortality is almost invariably due to metastasis [2], which
is a complex process involving a succession of cell bio-
logical events [3].
The process of epithelial–mesenchymal transition
(EMT) plays a key role in tumor metastasis [4]. Many
factors can stimulate the EMT process, during which
epithelial cells lose their polarity and cell–cell contacts,
acquire a migratory mesenchymal phenotype, and in-
crease resistance to chemotherapy and radiotherapy
[5,6]. The process of EMT coincides with the loss ofhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Shao et al. Molecular Cancer  (2015) 14:28 Page 2 of 17epithelial markers, such as E-cadherin and occludin, and
acquisition of mesenchymal markers, such as N-cadherin
and vimentin [7]. E-cadherin is a repressor of cancer inva-
sion and EMT induction [8,9]. A group of transcription
factors has been demonstrated to be capable of orchestrat-
ing EMT in cancer progression. Snail, Slug, and ZEB2/
SIP1 are direct transcriptional repressors of E-cadherin,
whereas Twist and ZEB1 act indirectly on E-cadherin [10].
The zinc-finger transcription factors Slug (Snail2) and
Snail (Snail1) belong to the Snail superfamily [11]. Slug
and Snail are two known important transcription factors
that initiate EMT through downregulation of E-cadherin
expression in breast cancer, and their expression has
been shown to be regulated by Notch signaling [12].
Interestingly, Slug expression presents a much stron-
ger correlation with loss of E-cadherin in breast cancer
cell lines than Snail expression, indicating that Slug is
a likely in vivo repressor of E-cadherin expression in
breast cancer [13].
Accumulating evidence demonstrates that Notch sig-
naling regulates many physiological processes, including
cell fate determination in the process of embryonic de-
velopment, tissue maturity, tumor cell proliferation, can-
cer stem cell maintenance, EMT, and chemoresistance
[14,15]. Notch receptors and ligands are single-pass
transmembrane proteins that regulate cell fate via cell–
cell contact [16,17]. Human Notch families have four
receptors (Notch1–4) and five ligands (Delta-like-1,
Delta-like-3, Delta-like-4, Jagged1, and Jagged2) [14].
Notch signaling is activated by ligand–receptor interac-
tions between neighboring cells, promoting γ-secretase-
dependent cleavage of the Notch receptor and releasing
the Notch intracellular domain (NICD) into the nu-
cleus, where the NICD binds to the transcription factor
CSL, resulting in activation of the pathway [16,18]. The
NICD/CSL complex causes the expression of target
genes, such as those of the Hairy enhancer of spit (Hes)
family.
The Notch signaling pathway is dysregulated in many
human malignancies. Overexpression of Notch receptors
and their ligands has been found in cervical, colon, head
and neck, lung, and renal carcinoma; pancreatic and
breast cancer; as well as acute myeloid, Hodgkin, and
large-cell lymphomas [19-21]. The first evidence that
Notch receptors are breast oncogenes was provided in
mouse studies in which active forms of Notch1 or
Notch4 formed spontaneous murine mammary tumors
in vivo [22]. Moreover, overexpression of Notch1 and/
or its ligand Jagged1 is related to the poorest overall
patient survival in human breast cancer [23-25]. Accu-
mulating evidence indicates that Notch1 cross-talk
with other major cell growth and apoptotic regulatory
pathways regulates the activity of transcription factors,
such as nuclear factor kappa B (NF-κB) [26]. However,the role of Notch signaling in regulating EMT remains
largely unknown.
In the current study, we found that Notch1 knockdown
in breast cancer cells suppressed the EMT process, tumor
growth, migration, and invasion using in vitro and in vivo
models. Jagged1-mediated Notch signaling activation was
able to activate the EMT process and increase migration
and invasion in breast cancer mainly though upregulation
of N1ICD, rather than Notch2 NICD (N2ICD), Notch3
NICD (N3ICD), or Notch4 NICD (N4ICD). Moreover,
we revealed that Notch1 signaling played a vital role
in regulating EMT mainly in a Slug-dependent man-
ner. Our findings indicate that Notch1 signaling is a
promising therapeutic target for preventing breast
cancer progression.
Results
Notch1 and Jagged1 are expressed in human breast
cancer cell lines
The NICD plays an important role in Notch signaling
activation. To investigate the possible role of the Notch
signaling pathway in initiation of the EMT process in
breast cancer cells, we first explored the expression
levels of the NICD of Notch1 (N1ICD) and its ligand
Jagged1 in five human breast cancer cell lines, human
mammary epithelial cells (HMECs), and non-tumorigenic
MCF-10A cells. As shown in Figure 1A, the expression
levels of the N1ICD protein were readily detectable in all
seven cell lines by western blot. In addition, the Notch1
and Jagged1 mRNA levels were tested by real-time poly-
merase chain reaction (PCR) (Figure 1B). Based on the
above results, MCF-7 and MDA-MB-231 cells were used to
study the Notch1/Jagged1 signaling pathway.
Stable Notch1 knockdown and Jagged1 were applied to
inhibit or activate Notch signaling, respectively, in breast
cancer cells
To investigate the role of Notch1 in Notch signaling, we
established stable shRNA-transfected cells termed as
MCF-7-shNotch1 and MDA-MB-231-shNotch1 (contain-
ing the Notch1 shRNA lentiviral vector), MCF-7-shNC,
and MDA-MB-231-shNC (containing the negative control
shRNA lentiviral vector). Western blot and real-time PCR
analyses showed that, compared with shNC cells, the ex-
pression levels of Notch1 were inhibited up to 80–90% in
both shNotch1 cell lines (P < 0.05, Figure 2A–B). Next, we
examined the expression levels of Hey1 and Hes1, down-
stream genes of the Notch signaling pathway. Consistent
with the reduction of Notch1, the expression levels of
these genes were significantly decreased in both MCF-7
and MDA-MB-231 cells (Figure 2C–D). Previous studies
have shown that Notch signaling strongly regulates the ac-
tivity of its downstream gene NF-κB, while NF-κB has
been identified to play an important role in the EMT
Figure 1 The expression of Notch1 and Jagged1 in human breast cancer cell lines. (A) The protein expression of N1ICD in a panel of
breast cancer cells (MDA-MB-231, T47D, MCF-7, ZR-75-1, and SK-BR-3), HMECs, and MCF-10A cells was evaluated by western blot. Protein
samples (150 μg) were separated by 10% SDS-PAGE. β-Actin was used as a loading control. (B) The mRNA expression of Notch1 and
Jagged1 was estimated by real-time PCR. GAPDH was used as a normalization control for quantifying the expression of each target gene.
Experiments were performed three times. Column: mean; bar: SD.
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NF-κB p65, a NF-κB subunit. Our results showed that NF-
κB p65 was downregulated by Notch1 knockdown in both
MCF-7 and MDA-MB-231 cells (Figure 2E–F).
To explore the effect of Notch signaling, Notch signal-
ing was activated by using an immobilized recombinant
Jagged1-Fc chimera in MCF-7 and MDA-MB-231 cells.
These two cell lines express multiple Notch receptors,
thus providing cells with the capability to activate the
Notch signaling pathway through ligand–receptor inter-
actions. After treatment with Jagged1 for 48 h, we de-
tected NICD expression of the four Notch receptors
(Notch1, Notch2, Notch3, and Notch4). As shown in
Additional file 1: Figure S1, both MCF-7 and MDA-MB-
231 cells showed an increased expression of N1ICD and
N4ICD. However, N2ICD and N3ICD were not signifi-
cantly changed. Moreover, the expression of N1ICD was
increased more than that of N4ICD, indicating that
Notch1 may have a dominant role in Jagged1-mediated
Notch signaling activation. Furthermore, the expression
levels of Hey1 and Hes1 were significantly increased in
both Jagged1-treated cell lines, compared with the nor-
mal group (Figure 2C–D). Interestingly, the downregula-
tion of Notch1 could only partially abolish the effect of
Jagged1-induced activation of Notch signaling on
Hey1 and Hes1 (Figure 2C–D). These results indicate
that Notch4 may be an alternate pathway to regulate
Jagged1-induced Hey1 and Hes1 expression, but thiseffect may be much weaker than Notch1 as Notch1
knockdown suppressed most of the Hey1 and Hes1 ex-
pression induced by Jagged1. Thus, our data indicate
that Hey1, Hes1, and NF-κB p65 are mainly regulated
by Notch1 signaling.Notch1 knockdown reverses the Jagged1-induced EMT
process in human breast cancer cells
EMT plays a critical role in the process of tumor migra-
tion and invasion [4]. To investigate whether Notch sig-
naling regulates the EMT process in breast cancer cells,
we established stable Notch1-shRNA-transfected cells
(MCF-7-shNotch1 cells and MDA-MB-231-shNotch1
cells) to inhibit Notch1 expression. When Notch1
shRNA was stably transfected into these two cell lines,
MDA-MB-231cells, which are more tumorigenic and
invasive, presented an obvious morphological change,
from the spindle phenotype (mesenchymal phenotype)
to a rounded or cobblestone phenotype (epithelial
phenotype) (Figure 3A). However, MCF-7 cells, which
exhibited a typical cobblestone-shaped phenotype with
less aggressive invasion ability, had no obvious mor-
phological change (Figure 3A). In contrast, immobi-
lized Jagged1-induced Notch activation transformed
the morphology of both cells from a cobblestone epi-
thelial phenotype to a spindle mesenchymal phenotype
(Figure 3B).
Figure 2 (See legend on next page.)
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Figure 2 Inhibition and activation of Notch signaling, respectively, in both MCF-7 and MDA-MB-231 cells. Normal group: MCF-7 or
MDA-MB-231 cells were incubated under normal conditions; shNC group: MCF-7 or MDA-MB-231 cells were stably transfected with NC shRNA;
shNotch1 group: MCF-7 or MDA-MB-231 cells were stably transfected with Notch1 shRNA; normal + Jagged1: MCF-7 or MDA-MB-231 cells were
treated with Jagged1 for 48 h; shNC + Jagged1 group: MCF-7 or MDA-MB-231 cells were treated with Jagged1 for 48 h after stable shNC transfection.
Jagged1 + shNotch1 group: MCF-7 or MDA-MB-231 cells were treated with Jagged1 for 48 h and then Notch1 shRNA was transiently transfected for
an additional 48 h. (A), (C), and (E) Total protein was isolated for western blot analysis using Notch1, Hey1, Hes1, and NF-κB65 antibodies. β-Actin was
used as a loading control. (B), (D), and (F) Total RNA was extracted, and the expression levels of Notch1, Hey1, Hes1, and NF-κB65 were assayed by
real-time PCR. The expression of every target gene was quantified using GAPDH as a normalization control. The data are from three independent
experiments. Column: mean; bar: SD. The symbol * represents a significant difference (P < 0.05).
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protein markers associated with EMT were also chan-
ged. The expression levels of the epithelial markers E-
cadherin and occludin were significantly increased in
both MCF-7-shNotch1 and MDA-MB-231-shNotch1
cells (Figure 3C–D). On the contrary, the expression
levels of the mesenchymal markers N-cadherin and
vimentin were markedly decreased (Figure 3C–D).
Meanwhile, immobilized Jagged1 ligand-induced Notch
signaling activation led to a prominent decrease in the
expression levels of the epithelial markers E-cadherin
and occluding (Figure 3C–D) and a significant increase
in the expression levels of N-cadherin and vimentin, as
compared with the normal group (Figure 3C–D). In
addition, nuclear protein was isolated to observe the
changes of β-catenin in the cell nucleus. In the normal
state, there was no expression of β-catenin in the nu-
cleus of MCF-7 cells and only a little expression in the
nucleus of MDA-MB-231 cells. Western blot assays
showed that after Notch1 interference, the expression
of β-catenin was not affected in the nucleus of MCF-7
cells, but it was reduced in the nucleus of MDA-MB-
231 cells (Figure 4A). Conversely, immobilized Jagged1
ligand-mediated Notch signaling activation led to increased
nuclear β-catenin (Figure 4A). After MCF-7 and MDA-
MB-231 cells were incubated with Jagged1 for 48 h, these
cells were transfected with Notch1 shRNA lentiviral vectors
for another 48 h; the results showed that the changes of
EMT markers induced by Jagged1 could be partially abro-
gated by Notch1 knockdown (Figure 3C–D; Figure 4A).
Meanwhile, immunofluorescence assays in MDA-MB-231
cells confirmed that Notch1 interference significantly in-
creased E-cadherin expression and decreased vimentin
expression (Figure 4B). In addition, immunofluorescence
assays in MCF-7 cells confirmed that Jagged1 significantly
decreased E-cadherin expression and increased vimentin
expression (Figure 5A). Taken together, our data showed
that Notch1 knockdown leads to the mesenchymal–epithe-
lial transition (MET) process, whereas Jagged1-induced
Notch signaling activation promotes the EMT process in
breast cancer cells.
To further investigate the correlation between Notch1
signaling and the EMT process in breast cancer, an
immobilized Jagged1 ligand was used to activate stableshNotch1-transfected cells (First, the stable shNotch1-
transfected cells were generated, and then stable shNotch1-
transfected cells were incubated with the immobilized
Jagged1 ligand for 48 h). As shown in Figure 5B–D, the ef-
fects of Notch1 interference on EMT could not be rescued
by Jagged1-induced Notch signaling activation. These data
indicate that Jagged1-mediated Notch signaling activation
promotes the breast cancer EMT process mainly through
activation of Notch1.
Notch1 knockdown suppresses Jagged1-induced migration
and invasion of breast cancer cells
Next, we investigated the effect of Notch1 on the migra-
tion and invasion in MCF-7 and MDA-MB-231 cells. As
shown in Figure 6A–B, Notch1 interference strongly
inhibited cell migration and invasion, compared with the
normal group and the shNC group in both cell lines.
However, Jagged1-mediated Notch signaling activation
notably enhanced the migration and invasion abilities in
both cell lines.
After MCF-7 and MDA-MB-231 cells were incubated
with Jagged1 for 48 h, these cells were transfected with
Notch1 shRNA lentiviral vectors for another 48 h; the
results showed that the enhanced migration and inva-
sion abilities that were due to Jagged1-mediated Notch
signaling activation were abolished by Notch1 silencing
(Figure 6A–B). However, in the stable shNotch1-
transfected cells (MCF-7-shNotch1 cells and MDA-
MB-231-shNotch1 cells), after incubation with Jagged1
protein for 48 h, the inhibited migration and invasion
abilities could not be restored by Jagged1-induced
Notch signaling activation (Figure 6A–B), suggesting
that Jagged1-induced Notch signaling activation pro-
motes the migration and invasion mainly through acti-
vation of Notch1.
N1ICD regulates Slug expression by inducing Slug
promoter activation in breast cancer
Transcription factors, such as Snail, Slug, ZEB1, Twist,
and ZEB2/SIP1, have been demonstrated to be capable
of orchestrating EMT in cancer progression [10]. There-
fore, we tested the expression levels of the above tran-
scription factors with Notch1 inhibition in MDA-MB-
231 human breast cancer cells. Interestingly, our results
Figure 3 (See legend on next page.)
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Figure 3 Characteristic of EMT under conditions of Notch1 knockdown or Jagged1 induced Notch signaling activation in breast cancer
cells. (A) and (B) Morphological changes of MCF-7 and MDA-MB-231 cells. (C) Total protein was extracted for immunoblotting analysis of the
EMT-related markers E-cadherin, occludin, N-cadherin, and vimentin in MCF-7 and MDA-MB-231 cells. β-Actin was used as a loading control.
(D) Real-time PCR analysis of the EMT-related markers E-cadherin, occludin, N-cadherin, and vimentin in MCF-7 and MDA-MB-231 cells. GAPAH
was used as a normalization control. The data are from three independent experiments. Column: mean; bar: SD. The symbol * represents a
significant difference (P < 0.05).
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protein levels of both Slug and Snail decreased, but the
Slug protein level decreased much more significantly
than that of Snail. However, the protein levels of
other transcription factors had no significant changes
(Additional file 1: Figure S2A–B).
Then, we examined whether Notch1 had a pivotal role
in regulating Slug expression in breast cancer. As shown
in Figure 7A-B, when Notch1 was silenced, both the
protein level and mRNA level of Slug were significantly
reduced in the Slug-positive MDA-MB-231 human
breast cancer cells. Similarly, Jagged1-induced Notch sig-
naling activation resulted in a marked increase in the ex-
pression of Slug in the MDA-MB-231 cells (Figure 7C-D).
To determine whether the altered Slug expression resulted
directly from the regulation of Notch1 or its downstreamFigure 4 The effects of Notch1 knockdown and Jagged1 on breast ca
and a β-catenin antibody was used to observe the changes of β-catenin in
(B) Immunofluorescence analysis of E-cadherin and vimentin in MDA-MB-2
E-cadherin and vimentin in their respective panels. The cells were observed
The data are from three independent experiments.proteins, Hes1 and Hey1 were also knocked down with siR-
NAs in MDA-MB-231 cells (Additional file 1: Figure S3A–
B). Our data showed that the protein expression level of
Slug did not change significantly with Hes1 or Hey1 inhib-
ition (Additional file 1: Figure S3C), suggesting that Slug is
a target gene of Notch1 but not the downstream gene of
Hey1 or Hes1. Based on the above data, we speculated that
Notch1 might have participated in the transcriptional
regulation of Slug. To validate this hypothesis, we per-
formed a promoter assay by using the N1ICD overex-
pression plasmid pcDNA3.1(+) or its negative control
plasmid pcDNA3.1 co-transfected with the reporter
constructs of the pGL3-Slug promoter (from −2000
to +100 relative to the transcription start site) or its
negative control pGL3-basic, respectively (Figure 7E).
As shown in Figure 7F, N1ICD significantly increasedncer EMT. (A) Nuclear protein was extracted for western blot analysis,
the nucleus. LaminB1 was used as a loading control for nuclear lysate.
31 cells. DAPI staining was used to detect nuclei and is merged with
under an immunofluorescence microscope at 400× magnification.
Figure 5 Jagged1-mediated activation of Notch signaling induces EMT and cannot rescue the changes caused by Notch1 interference.
shNotch1 + Jagged1 group: MCF-7 or MDA-MB-231 cells were treated with Jagged1 for 48 h after stable shNotch1 transfection. (A) Immunofluorescence
analysis of E-cadherin and vimentin in MCF-7 cells. DAPI staining was used to detect nuclei and is merged with E-cadherin and vimentin in their respective
panels. The cells were observed under an immunofluorescence microscope at 400× magnification. (B) Western blot analysis of the EMT-related markers
E-cadherin, occludin, N-cadherin, and vimentin in MCF-7 and MDA-MB-231 cells. (C) The mRNA expression levels of E-cadherin, occludin, N-cadherin,
and vimentin were estimated by real-time PCR. (D)Western blot analysis of nuclear β-catenin in MCF-7 and MDA-MB-231 cells. The data are from three
independent experiments. Column: mean; bar: SD. The symbol * represents a significant difference (P < 0.05).
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Figure 6 Notch1 knockdown inhibits Jagged1-enhanced breast cancer migration and invasion. (A) and (B) The cells were seeded into a
migration chamber or a Matrigel-coated invasion chamber and incubated for 24 h. The number of migrated cells was quantified by counting the
numbers of cells from six random fields at 100× magnification. The data are from three independent experiments. There are similar numbers of
migrated and invaded breast cancer cells between the Normal + Jagged1 and the shNC + Jagged1 groups of cells (data not shown). Column: mean;
bar: SD. The symbol * represents a significant difference (P < 0.05).
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transfected control in the pGL3-Slug promoter group, but
not in the pGL3-basic group. These results indicate that
N1ICD regulated Slug expression by inducing Slug pro-
moter activation at the transcription level.
Slug serves as a mediator for Notch1-induced EMT
To explore whether Notch1 exerts its function through
its target gene Slug, we knocked down Slug expression
by Slug siRNA in MDA-MB-231 cells (Figure 8A–B)
and determined the expression levels of EMT markers
by western blot assays. The Slug-knocked down cellsdisplayed increased E-cadherin and decreased vimentin
expression levels. Moreover, Jagged1-mediated Notch sig-
naling activation could partially rescue these changes
(Figure 8C). We further examined the migration and inva-
sion abilities of MDA-MB-231 cells transfected with Slug
siRNA. Downregulation of Slug strongly inhibited cell
migration and invasion, whereas Jagged1 could partially
restore the migration and invasion (Figure 8D–E).
Next, we focused on the role of the transcription fac-
tor Slug in the Notch1-induced EMT process. If Slug ex-
pression is important to the Notch1-induced EMT, the
upregulation of Slug is expected to restore the EMT
Figure 7 Notch1 regulates Slug expression by enhancing its promoter activity. (A) and (B) The level of Slug expression was evaluated by
western blot and real-time PCR after MDA-MB-231 cells were stably transfected with shNC or shNotch1. (C) and (D) The Slug expression level
following treatment with Jagged1 ligand for 48 h was estimated by western blot and real-time PCR. (E) The schematic diagram shows the
construction of the pGL3-Slug promoter and its negative control pGL3-basic. (F) Luciferase reporter assays were carried out in MDA-MB-231 cells,
which were cotransfected with the pGL3-Slug promoter or its negative control pGL3-basic and N1ICD overexpression plasmid pcDNA3.1(+) or its
negative control plasmid pcDNA3.1. Each independent experiment was repeated three times. Column: mean; bar: SD. The symbol * represents a
significant difference (P < 0.05).
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possibility, stable MDA-MB-231-shNC cells or MDA-
MB-231-shNotch1 cells were transfected with pcDNA3.1
(+)-vector or pcDNA3.1(+)-Slug for 48 h. Western blot
analysis indicated that overexpression of Slug reduced the
expression of the epithelial marker E-cadherin and par-
tially restored the expression of the mesenchymal marker
vimentin (Figure 8F). Moreover, Slug upregulation prom-
inently enhanced the migration and invasion abilities of
MDA-MB-231-shNotch1 cells (Figure 8G–H). These re-
sults indicated that Slug plays a key role in Notch1 signal-
ing to regulate EMTand invasion in breast cancer cells.
Notch1 silencing reverses EMT in breast cancer in vivo
In vitro experiments have revealed that Notch1 silencing
reverses the EMT process and inhibits metastasis in
breast cancer cells, which prompted us to investigate
whether downregulation of Notch1 can regulate EMT
in vivo. Stable shRNA-transfected cells (MDA-MB-231-shNotch1 and MDA-MB-231-shNC) were orthotopically
injected into the mammary fat pads of 6-week-old fe-
male nude mice. The tumor growth curve showed that
the tumors of the MDA-MB-231-shNotch1 group grew
much more slowly than those of the MDA-MB-231-
shNC group (Figure 9A–B). Immunohistochemical ana-
lysis displayed a decrease in the N-cadherin level but an
increase in the E-cadherin level (Figure 9C), which rep-
resents the MET phenotype.
Discussion
In the current study, our data showed that inhibition of
Notch1 reversed the EMT process both in vitro and
in vivo, and inhibited migration and invasion in breast
cancer cells. We found a positive association between
Notch1 signaling and breast cancer invasion and pro-
gression, thus presenting a potential oncogenic role.
Moreover, our study identified that EMT induced by
Jagged1 is mainly through Notch1-induced Notch
Figure 8 (See legend on next page.)
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Figure 8 Slug serves as a mediator for Notch1-induced EMT, migration, and invasion. (A) and (B) Western blot analysis and real-time PCR
assays were carried out to evaluate the expression of Slug when MDA-MB-231 cells were transfected with negative control siRNA (siNC) or Slug
siRNA (siSlug) for 48 h. (C) MDA-MB-231 cells were transfected with siNC or siSlug for 48 h and then treated with Jagged1 for an additional 48 h.
E-cadherin and vimentin protein levels were evaluated by western blot. (D) and (E) MDA-MB-231 cells were transfected with siNC or siSlug for
48 h and then treated with Jagged1 for an additional 48 h. The cells were seeded into a migration chamber or a Matrigel-coated invasion
chamber and incubated for 24 h. The number of migrated cells was counted under a light microscope. (F) MDA-MB-231-shNC or MDA-MB-231-shNotch1
cells were transfected with negative control vector (pcDNA3.1) or Slug overexpression vector (pcDNA3.1-Slug), respectively. Forty-eight hours later, western
blot analysis was performed to assess the expression levels of E-cadherin and vimentin. (G) and (H) MDA-MB-231-shNotch1 cells were transfected with
pcDNA3.1 or pcDNA3.1-Slug for 48 h and then the migration and invasion abilities were evaluated. The data are from three independent experiments.
Column: mean; bar: SD. The symbol * represents a significant difference (P < 0.05).
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gene of Notch1 signaling in regulating the EMT process.
Notch signaling, which plays a critical role in tumor
pathology and progression, is frequently observed in
breast cancer and other solid tumors [28]. Recently,
several studies have revealed that overexpression ofFigure 9 Downregulation of Notch1 reverses EMT in vivo. (A) Tumo
MDA-MB-231-shNotch1 cells was significantly smaller than that of the c
SD, n = 4 per group, the symbol * represents a significant difference (P
without Notch1 downregulation. (C) Representative images of immuno
N-cadherin as well as hematoxylin and eosin staining (magnification: 40Notch1 and/or Jagged1 indicates a poor prognosis
for breast cancer patients. Furthermore, the Notch sig-
naling pathway is related to a number of protumori-
genic activities in breast cancer cell lines and can
cause mammary hyperplasia and carcinogenesis in
mice [29-32]. A study on human breast cancer hasr growth curve. The tumor volume in nude mice injected with
ontrol MDA-MB-231-shNC cells. Tumor volumes represent means ±
< 0.05). (B) In vivo metastasis assays of MDA-MB-231 cells with or
histochemical staining for the EMT-related markers E-cadherin and
0×). The data are from three independent experiments.
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regulator of Notch signaling, is reduced in 50% of human
breast tumors [33]. Notch1 has also been found to be a
downstream effector of the oncogenic gene Ras in human
mammary tumorigenesis [34]. Although there is abundant
evidence demonstrating that the Notch signaling pathway
is closely associated with human breast cancer develop-
ment, our study has provided novel insights into the role
of Notch1 signaling in regulating EMT and invasion
mainly in a Slug-dependent manner.
Invasion and metastasis are two of the most important
features of malignant tumors, the main cause of cancer-
related death, and the most difficult problem in clinical
treatment. EMT is a key step in tumor invasion and me-
tastasis. Our study results emphasize the key role of the
Notch1 signaling pathway in regulating EMT via the
transcription factor Slug during cancer cell invasion and
metastasis, using both in vitro and in vivo models. Our
data showed that the expression of the Notch signaling
downstream genes Hes1 and Hey1 decreased in breast
cancer cells with Notch1 inhibition. In contrast, the
expression levels of Hes1 and Hey1 were significantly in-
creased during Notch signaling pathway activation in-
duced by Jagged1. These data indicate that both Hes1
and Hey1 are sensitive Notch target genes for the Notch
signaling pathway. While previous studies have shown
that both Hes1 and Hey1 are sensitive Notch target
genes, Hey is more sensitive than Hes gene for Notch
pathway inhibition in breast cancer [35]. Recently, a few
other Notch target genes have been found, including
NF-κB, cyclinD1, c-myc, p21, p27, Akt, mTOR, VEGF,
etc. [20,21,36]. In this study, our data also showed that
NF-κB p65 expression was dramatically downregulated
by Notch1 knockdown in breast cancer cells. Similarly, a
recent report has revealed that Notch signaling pathway
inhibition results in decreased NF-κB in pancreatic
cancer cells, suggesting a molecular link or cross-talk
between Notch and NF-κB; furthermore, activation of
these signaling pathways is associated with acquisition of
the EMT phenotype [37].
Previous studies have demonstrated that Jagged1-
induced Notch signaling activation induces EMT through
Slug-mediated repression of E-cadherin [35]. A recent
study has shown that Notch1 mediates esophageal carcin-
oma cell invasion and metastasis by inducing EMT
through upregulation of Snail [38]. Likewise, our study
showed that the EMT process was closely related to
Notch1 signaling in breast cancer cells. Notch1 silencing
could reverse the EMT process and lead to MET. The
MET program is characterized by increased E-cadherin
and occludin expression, and decreased N-cadherin,
vimentin, and nuclear β-catenin, which leads to the acqui-
sition of an epithelial phenotype. Meanwhile, breast cancer
cell migration and invasion abilities were inhibited byNotch1 interference. Furthermore, our data showed that
the EMT process was largely driven by Jagged1-induced
Notch signaling activation. This EMT program displayed a
significant reduction of E-cadherin and occludin expres-
sion, and a marked increase of N-cadherin, vimentin,
and nuclear β-catenin expression, resulting in cancer
cells evolving into a highly invasive and mesenchymal
phenotype. A recent study has reported that EMT re-
sults in a loss of E-cadherin, which impairs cell–cell
adhesion and allows nuclear localization of β-catenin
[39]. Apparently, our findings are in concordance with
this study. Notably, culturing breast cancer cells with
soluble Jagged1 protein induced EMT and increased
their migration and invasion, which could be partially
abolished by Notch1 knockdown. These data indicate
that the Jagged1–Notch1 axis plays an important role
in promoting EMT and invasion in breast cancer. In
addition, Chen et al. have shown that inhibition of
Notch signaling abrogates the downregulation of E-
cadherin and increases migration and invasion under
hypoxic conditions in breast cancer [12]. Interestingly,
our results showed that Jagged1 could not rescue the
changes caused by downregulation of Notch1. Jagged1
ligand-triggered Notch activation is mainly mediated
by the interaction between Notch ligands and recep-
tors. Our data also showed that Jagged1 could cause a
significant upregulation of N1ICD and less upregulation
of N4ICD. Our study provides noteworthy evidence that
the Jagged1 ligand can interact with Notch1 to activate
Notch signaling and promote EMT.
Slug and Snail are associated with EMT during both
embryonic development and cancer metastasis [40,41].
Our data showed that Notch1 knockdown mainly de-
creased Slug expression, compared with the other tran-
scription factors. Downregulation of Slug resulted in a
significant increase of E-cadherin expression and a
prominent decrease of the vimentin level, and weakened
the migration and invasion capacities in breast cancer
cells. Importantly, the Notch1-reversed EMT was restored
by the overexpression of Slug. Furthermore, Notch1 was
found to be more effective at downregulating the Slug ex-
pression levels than Hes1 and Hey1. This result led us to
investigate whether Slug expression was directly regulated
by Notch1 at the transcriptional level. The luciferase re-
porter assay further demonstrated that Notch1/NICD
positively regulated Slug expression by enhancing Slug
promoter activity. In light of our studies, Notch1 might
downregulate Slug to maintain the epithelial phenotype
and inhibit the migration and invasion behavior of breast
cancer cells. The Notch1–Slug axis might play an import-
ant role in breast cancer progression. However, the
detailed mechanism by which the Notch1–Slug axis
regulates EMT remains unclear, and much work needs
to be done in the future.
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naling activation induced by Jagged1 partially inhibited
the upregulation of E-cadherin and the downregulation
of vimentin caused by Slug interference. These data sug-
gest that Notch signaling could bypass Slug to trigger
some other factors to regulate EMT. Leong et al. have
reported that Notch signaling activation targets Slug, not
Snail or Twist, to suppress E-cadherin and initiate the
EMT process [35]. However, Chen et al. have shown
that Notch signaling activation under hypoxic condi-
tions could increase the expression of Slug and Snail to
initiate EMT [12].
Taken together, our observations imply that Jagged1-
triggered Notch signaling activation is mainly dependent
on Notch1. Slug serves as a mediator, which contributes
to the enhanced migration and invasion in breast cancer
cells. EMT is initiated mainly though the Notch1–Slug
signaling axis. Thus, Slug plays a key role in Notch1
signaling that modulates EMT and metastasis in breast
cancer.
Conclusion
Tumor metastasis is a main cause of mortality in cancer
patients. EMT favors tumor metastasis and recurrence.
Notch1 knockdown increased E-cadherin expression and
reversed EMT in vitro and in vivo, and inhibited the motil-
ity and invasion capacities of breast cancer cells. In
addition, the Notch1–Slug axis was shown to be vital for
the Jagged1-induced promotion of EMT and invasion in
breast cancer. Here, we provide evidence for the Notch1–
Slug signaling axis in breast cancer cells to promote EMT
and further enhance the capacity of migration and inva-
sion, which may improve our understanding of the regula-
tory networks governing EMT and cancer progression.
Our results highlight the potential use of Notch1 signaling
or Slug inhibitors to prevent breast cancer progression.
Materials and methods
Cell culture
The human breast cancer cell lines (MCF-7, MDA-MB-
231, SK-BR-3, T47D, and ZR-75-1) used in this study
were purchased from the Cell Bank of Type Culture
Collection of the Chinese Academy of Sciences (Shanghai,
China). Human mammary epithelial cells (HMECs) and
non-tumorigenic MCF-10A cells were obtained from the
American Type Culture Collection. The human breast
cancer cells were cultured in DMEM, RPMI-1640, or
McCoy’s 5A medium, respectively, according to the rec-
ommended culture method. All media were supplemented
with 10% fetal bovine serum (FBS; Gibco, Grand Island,
NY, USA) and 1% penicillin-streptomycin. All cells were
grown at 37°C in an atmosphere of 5% CO2. The culture
methods used for HMECs and MCF-10A cells were as
described previously [42].Notch signaling activation by using immobilized
recombinant Notch ligands
The Notch signaling activation assay was performed as
described previously [43]. Cell culture plates were coated
with 50 μg/ml Protein G (Zymed, USA) in phosphate-
buffered saline (PBS) at room temperature overnight.
The plates were washed with PBS three times and
blocked with 10 mg/ml bovine serum albumin (BSA) in
PBS for 2 h at room temperature. The blocked plates
were then washed with PBS and incubated with recom-
binant Jagged1-FC chimera (R&D Systems, USA) at a
concentration of 3 μg/ml in 0.1% BSA/PBS for 3 h at
room temperature. After washing three times with PBS,
the cells were immediately seeded in the coated plates
using the culture medium as described above. The sche-
matic diagram of this Notch signaling activation method
is shown in Additional file 1: Figure S4.
Notch1 shRNA lentivirus transfection
Notch1 shRNA (shNotch1) and negative control (shNC)
in eukaryotic GV248 lentiviral vectors were purchased
from GeneChem Co., Ltd. (Shanghai, China). The target
sequence for Notch1 shRNA was GTCCAGGAAACAA
CTGCAA. The cells were seeded at 1 × 103 cells/well
into 96-well plates at 24 h prior to transfection. When
the cells grew to 30–70% confluence, transfection was
carried out by using lentiviral particles (MCF-7 multipli-
city of infection (MOI) = 20; MDA-MB-231 MOI = 10),
polybrene (5 μg/ml), and enhanced infection solution
(GeneChem Co., Ltd., Shanghai, China), according to
the manufacturer’s protocol. At 12 h post-transfection,
virus-containing medium was replaced with complete
medium. At 96 h post-transfection, all cells were se-
lected by puromycin (Merck, USA) at a final concentra-
tion of 5 μg/ml (MCF-7) or 4 μg/ml (MDA-MB-231) for
10 days. Then, the cells were maintained in 2.5 μg/ml
(MCF-7) or 2 μg/ml (MDA-MB-231) puromycin. To
generate stable transfected cells, 100 transfected cells
were seeded into a 10-cm Petri dish, and the medium
was changed three times per week. After 3 weeks,
puromycin-resistant colonies were isolated and seeded
into 96-well plates for further study. The 954-bp coding
sequence of Slug was amplified by PCR from the cDNAs
of MDA-MB-231 cells and subcloned into pcDNA3.1 (+)
by EcoR V and EcoR I (Shanghai Genechem Co., Ltd,
China).
RNA interference
The siRNAs for Slug (5′-GCAUUUGCAGACAGGU-
CAAdTdT-3′, 5′-UUGACCUGUCUGCAAAUGCdTdT-
3′), Hey1 (5′-CAGUUUGUCUGAGCUGAGATT-3′, 5′-
UCUCAGCUCAGACAAACUGTT-3′), Hes1 (5′-AGGC
UGGAGAGGCGGCUAATT-3′, 5′-UUAGCCGCCUCUC
CAGCCUTT-3′), and negative control (NC: 5′-UUC
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CGGAGAATT-3′) were synthesized by GenePharm
(Shanghai, China). Cells (5 × 104 per well) were seeded
in six-well plates 24 h prior to transfection and trans-
fected with 80 pM siRNA using TurboFectTM siRNA
Transfection Reagent (Fermentas, Beijing, China), ac-
cording to the manufacturer’s protocol.
Western blot analysis and antibodies
The cells were harvested, and total protein was extracted
from the stable cell lines. Nuclear protein was isolated
according to the manufacturer’s instructions (Pioneer
Biotechnology, Inc.). Equal amounts of protein (150 μg)
were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (10% SDS-PAGE) and then trans-
ferred onto a polyvinylidene difluoride (PVDF) mem-
brane (Roche). The immunoblots were incubated in 5%
(w/v) skim milk powder dissolved in TBST (10 mM
Tris–HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween-20)
for 2 h at room temperature. Next, the blots were
probed first with specific antibodies and then with the
appropriate secondary antibodies.β-Actin or LaminB1
was used as a control. Signals were quantified using
Image-Pro Plus 6.0 software (Media Cybernetics).
Antibodies were purchased from the following sources:
anti-Notch1 antibody (Cell Signaling Technology, Boston,
MA, USA), anti-NF-κB65 antibody (Cell Signaling Tech-
nology), anti-Hey1 antibody (Abcam, Cambridge, MA,
USA), anti-Hes1 antibody (Cell Signaling Technology),
anti-E-cadherin antibody (Cell Signaling Technology),
anti-N-cadherin antibody (Abcam), anti-vimentin anti-
body (Cell Signaling Technology), anti-occludin anti-
body (Proteintech Group Inc., USA), anti-Slug antibody
(Abcam), anti-β-catenin antibody (Cell Signaling Tech-
nology), anti-Snail (Proteintech Group Inc.), anti-Twist
antibody (Proteintech Group Inc.), anti-ZEB1 (Cell Signa-
ling Technology), anti-ZEB2 (Abcam), anti-β-actin anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA, USA),
anti-LaminB1 antibody (Santa Cruz Biotechnology),
anti-N2ICD (Santa Cruz Biotechnology), anti-N3ICD
(Santa Cruz Biotechnology), and anti-N4ICD (Santa
Cruz Biotechnology).
RNA extraction and quantitative real-time PCR
Total RNA was isolated from breast cancer cells using
TRIzol reagent (Invitrogen, CA, USA). cDNA was synthe-
sized by using a PrimeScript RT reagent kit (Fermentas,
Beijing, China). The real-time PCR was carried out using
a SYBR Green PCR Kit (TaKaRa, Dalian, China), accord-
ing to the manufacturer’s instructions. GAPDH was used
as an internal control, and the relative expression levels
were assessed using the ΔΔCt method. The sequences
of the primers for real-time PCR are listed in Additional
file 1: Table S1.In vitro cell migration and invasion assays
In the cell migration assay, equal numbers of cells (5 × 104
cells/well) were suspended in the top compartment of a
24-well chamber (Millipore Co., Billerica, MA, USA) in
300 μl of DMEM (MCF-7 cells) or RPMI 1640 (MDA-
MB-231 cells) containing 0.1% BSA. Then, 600 μl of
DMEM containing 15% FBS or RPMI 1640 containing
10% FBS was added into the bottom compartment. The
cells were incubated for 24 h. Then, the nonmigrated cells
were removed from the membrane of the top compart-
ment with a cotton swab, and the cells that had migrated
through the membrane were fixed and stained in 4% para-
formaldehyde and 0.01% crystal violet solution. The num-
bers of cells that migrated were determined from six
random high-power fields (HPFs) visualized at 100× mag-
nification, and means were obtained for statistical analysis.
The invasion assays were performed in a similar man-
ner as the migration assays, except that the cells were
placed in the upper compartment with a Matrigel (BD
Biosciences, San Jose, CA, USA)-coated membrane, as
previously described [44]. The numbers of invading cells
were quantified from six random HPFs visualized at
100× magnification.
Immunofluorescence
A total of 2 × 104 cells per well were grown on glass cov-
erslips in a 24-well plate overnight. The next day, when
the cells were 50–70% confluent, they were washed
twice with PBS, then fixed in 4% paraformaldehyde solu-
tion, and permeabilized in 0.03% Triton X-100 (Sigma)
in PBS for 20 min. The cells were then washed three
times (5 min each time) with PBS and blocked with 5%
BSA in PBS for 1 h at room temperature. The cells on
the coverslips were incubated in a humidified box with
the respective primary antibodies at a 1:100 dilution
overnight at 4°C. Next, the cells were washed three times
(5 min each time) in PBS and incubated for 1 h with
CY3-conjugated secondary antibodies at a 1:50 dilution
(CWBIO, Beijing, China) at room temperature in the
dark. Finally, the cells were washed three times in PBS
and incubated with 1 μg/ml 4, 6-diamidino-2-phenylin-
dole (DAPI, Roche) for 5 min at room temperature in
the dark. Then, the slides were washed extensively with
PBS and observed with an immunofluorescence micro-
scope (Nikon, Japan) with identical exposure times at
400× magnification.
Luciferase reporter assays
The cDNA encoding N1ICD was subcloned into the ex-
pression vector pcDNA3.1(+) between the BamHI and
XhoI sites, and subcloning was confirmed with sequen-
cing by Shanghai Genechem Co., Ltd. The pGL3 re-
porter construct plasmid (−2000/+100) consisted of a
2100-bp genomic DNA fragment of the Slug promoter
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plasmid or its negative control pGL3-basic plasmid carry-
ing the firefly luciferase reporter were co-transfected with
an internal control, pRL-TK Renilla vector (Promega), by
using Lipofectamine 2000 (Invitrogen). In addition, cells
were respectively transfected with 600 ng of N1ICD over-
expression plasmid pcDNA3.1(+) or its negative control
pcDNA3.1. Cell lysates were harvested 48 h after transfec-
tion. The firefly and renilla activities were measured by
the Dual-Luciferase Reporter Assay System (Promega).
Firefly luciferase activity was normalized to the Renilla
luciferase activity. Each transfection was repeated three
times.
Animal studies
Animal experiments were performed in accordance with
the Animal Care and Use Committee guidelines of Xi’an
Jiao Tong University, Shaanxi, China. The mice were
divided into two groups, with four per group. The cells
were resuspended in a 1:1 (v/v) mixture of culture media
and Matrigel (BD Biosciences, San Jose, CA, USA), and
2 × 106 MDA-MB-231 cells were orthotopically injected
into the mammary fat pads of 6-week-old female nude
mice (Silaike Laboratory Animal Co., Ltd., Shanghai,
China). Tumor growth was observed twice per week
with calipers at the site of injection. After 38 days, the
animals were observed by an IVIS imaging system (IVIS
spectrum, Xenogen, CA, USA), then they were sacri-
ficed, and the mammary tumors were isolated for im-
munohistochemical staining.
Immunohistochemistry
Sections of paraffin-embedded, formalin-fixed tumor tis-
sues were deparaffinized in xylene and rehydrated in a
series of graded ethanol solutions, and exposed to micro-
wave radiation in a citrate buffer (pH = 6.0) for 15 min.
Endogenous peroxidase activity was blocked with 3%
H2O2 in methanol for 5 min at room temperature. The
sections were washed three times with PBS and incubated
with goat serum for 20 min at room temperature. Next,
the sections were incubated with the primary antibodies
overnight at 4°C. The sections were warmed to room
temperature, then washed three times with PBS, incubated
with biotinylated secondary antibodies for 30 min at room
temperature, and washed again, after which immune com-
plexes were detected with the use of a streptavidin-
peroxidase complex (DAKO) and 3,3′-diaminobenzidine
(DAB, DAKO). The sections were counterstained with
hematoxylin, dehydrated in a graded series of alcohol solu-
tions, and mounted in Malinol (Muto Pure Chemicals).
Statistical analysis
All data are presented as the mean ± standard deviation
(SD). Data were analyzed by one-way analysis of variance(ANOVA) or two-way ANOVA as appropriate. Statistical
analysis was performed with SPSS 13.0 for Windows
software (SPSS Inc., Chicago, IL, USA). All statistical
tests were two-sided, and P values less than 0.05 were con-
sidered statistically significant. In all figures, (*) denotes P
< 0.05. All experiments were repeated independently at
least three times.Additional file
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